A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma

• Main Authors: Yifei Liu (Author), Tingting Bian (Author), Yanlin Zhang (Author), Yuanyuan Zheng (Author), Jianguo Zhang (Author), Xiaoge Zhou (Author), Jianlan Xie (Author)
• Format: Book
• Published: BMC, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background To evaluate the clinical utility of LIM Domain Only 2 (LMO2) negative and CD38 positive in diagnosis of Burkitt lymphoma (BL). Methods LMO2 and CD38 expression determined by immunohistochemistry in 75 BL, 12 High-grade B-cell lymphoma, NOS (HGBL,NOS) and 3 Burkitt-like lymphomas...